ASX:MSBBiotechs
Has Mesoblast’s Surging Share Price Left Its Future Growth Prospects Underappreciated?
If you are wondering whether Mesoblast is a hidden bargain or a value trap at its current share price, you are not alone. This breakdown aims to unpack that question.
The stock has been choppy in the short term, down 1.8% over the last week. That comes after a 24.8% jump over the past month and a 42.8% gain over the last year, all against a still negative year to date return of 17.3% and a 215.8% rise over three years.
Recent moves have been driven less by day to day noise and more by...